SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-20-000060
Filing Date
2020-06-01
Accepted
2020-06-01 16:04:23
Documents
18
Period of Report
2020-05-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx1jun2020.htm   iXBRL 8-K 55255
2 EXHIBIT 99.1 a991.htm EX-99.1 63949
3 EXHIBIT 99.2 a992.htm EX-99.2 34438
9 asconsclc528enimage1.jpg GRAPHIC 8672
10 ascozanu528enimage1.jpg GRAPHIC 8672
  Complete submission text file 0001651308-20-000060.txt   348004

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20200601.xsd EX-101.SCH 4296
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20200601_cal.xml EX-101.CAL 622
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20200601_def.xml EX-101.DEF 1472
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20200601_lab.xml EX-101.LAB 27192
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20200601_pre.xml EX-101.PRE 14088
19 EXTRACTED XBRL INSTANCE DOCUMENT a8-kx1jun2020_htm.xml XML 4541
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 20933409
SIC: 2834 Pharmaceutical Preparations